Predicted protein targets (top 10)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | CYP3A4 | P08684 | 2/20 | 0.56 |
| ▸ | GLI1 | P08151 | 1/20 | 0.56 |
| ▸ | GLI2 | P10070 | 1/20 | 0.56 |
| ▸ | MEN1 | O00255 | 1/20 | 0.37 |
| ▸ | CNR2 | P34972 | 1/20 | 0.37 |
| ▸ | KMT2A | Q03164 | 1/20 | 0.37 |
| ▸ | PPARA | Q07869 | 1/20 | 0.37 |
| ▸ | PTPN1 | P18031 | 1/20 | 0.35 |
| ▸ | STAT3 | P40763 | 1/20 | 0.35 |
| ▸ | MET | P08581 | 1/20 | 0.31 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Alpha-Humulone SCHEMBL30712204 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL157914 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL31668762 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL29422612 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL23460398 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL17629686 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL23781774 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL106386 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| SCHEMBL29356602 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 | |
| Alpha-Humulone SCHEMBL4211645 | 1.00 | CYP3A4 (0.56) | CYP3A4GLI1GLI2MEN1CNR2 |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-4543229-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2025-04-30 | — | — | EP | disclosed |
| WO-2023248187-A1 | ORAL COMPOSITION COMPRISING A RECEPTOR MODULATOR | Nicoventures Trading Limited (GB) | 2023-12-28 | — | — | WO | disclosed |